FDA expands Susvimo’s indications to include diabetic retinopathy
Hypoglycemia may promote a breakdown of the blood-retinal barrier, study finds
ARVO 2025: Lens thickness as a significant biomarker for accommodation in presbyopia
US FDA gives Atia Vision go-ahead to begin clinical study of the OmniVu Lens System